Original language | English (US) |
---|---|
Pages (from-to) | 2205-2241 |
Number of pages | 37 |
Journal | Journal of the American College of Cardiology |
Volume | 54 |
Issue number | 23 |
DOIs | |
State | Published - Dec 1 2009 |
Externally published | Yes |
Keywords
- ACCF/AHA practice guidelines
- ST-elevation myocardial infarction
- antiplatelet therapy
- focused update
- glycoprotein IIb/IIIa receptor antagonists
- parenteral anticoagulants
- percutaneous coronary intervention
- thienopyridines
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of the American College of Cardiology, Vol. 54, No. 23, 01.12.2009, p. 2205-2241.
Research output: Contribution to journal › Review article › peer-review
}
TY - JOUR
T1 - 2009 Focused Updates
T2 - ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update).
AU - Kushner, Frederick G.
AU - Hand, Mary
AU - Smith, Sidney C.
AU - King, Spencer B.
AU - Anderson, Jeffrey L.
AU - Antman, Elliott M.
AU - Bailey, Steven R.
AU - Bates, Eric R.
AU - Blankenship, James C.
AU - Casey, Donald E.
AU - Green, Lee A.
AU - Hochman, Judith S.
AU - Jacobs, Alice K.
AU - Krumholz, Harlan M.
AU - Morrison, Douglass A.
AU - Ornato, Joseph P.
AU - Pearle, David L.
AU - Peterson, Eric D.
AU - Sloan, Michael A.
AU - Whitlow, Patrick L.
AU - Williams, David O.
N1 - Funding Information: The ACCF/AHA Task Force on Practice Guidelines makes every effort to avoid actual, potential, or perceived conflicts of interest that may arise as a result of industry relationships or personal interests among the writing committee. Specifically, all members of the writing committee, as well as reviewers of the document, are asked to disclose all such relevant relationships pertaining to the trials and other evidence under consideration (see Appendixes 1, 2, and 3 ). All guideline recommendations require a confidential vote by the writing group and must be approved by a consensus of the members voting. Members who recused themselves from voting are noted on the title page of this document. Members must recuse themselves from voting on any recommendations to which their relationships with industry and other entities apply. Writing group members who did not participate are not listed as authors of this focused update. The work of the writing group was supported exclusively by the ACCF and AHA without commercial support. Writing group members volunteered their time for this effort.
PY - 2009/12/1
Y1 - 2009/12/1
KW - ACCF/AHA practice guidelines
KW - ST-elevation myocardial infarction
KW - antiplatelet therapy
KW - focused update
KW - glycoprotein IIb/IIIa receptor antagonists
KW - parenteral anticoagulants
KW - percutaneous coronary intervention
KW - thienopyridines
UR - http://www.scopus.com/inward/record.url?scp=70450199115&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70450199115&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2009.10.015
DO - 10.1016/j.jacc.2009.10.015
M3 - Review article
C2 - 19942100
AN - SCOPUS:70450199115
SN - 0735-1097
VL - 54
SP - 2205
EP - 2241
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 23
ER -